EV Biologics, Inc. (YECO)

EV Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2017	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2017	Dec 31, 2017	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014
Cash & Equivalents	8.39	8.39	1.81	2.73	16.47	19.73
Short-Term Investments	4.02	4.02	-	-	-	-
Cash & Short-Term Investments	12.4	12.4	1.81	2.73	16.47	19.73
Cash Growth	365.64%	583.85%	-33.67%	-83.40%	-16.53%	240.65%
Accounts Receivable	1.03	1.03	4.97	5.73	9.33	5.18
Other Receivables	-	-	0.02	0.02	-	-
Receivables	1.03	1.03	4.98	5.74	9.33	6.11
Inventory	0.13	0.13	0.21	0.36	0.36	0.42
Prepaid Expenses	0.11	0.11	0.08	0.11	0.37	0.07
Restricted Cash	-	-	0.5	0.5	-	-
Other Current Assets	38.38	38.38	1.33	1.21	0.3	0.41
Total Current Assets	52.05	52.05	8.91	10.66	26.84	26.75
Property, Plant & Equipment	5.16	5.16	6.66	7.43	41.27	34.38
Other Intangible Assets	1.75	1.75	2.07	2.16	4.91	2.83
Long-Term Deferred Tax Assets	-	-	0.16	0.39	0.52	0.19
Other Long-Term Assets	-	-	15.49	15.8	4.06	5.4
Total Assets	58.95	58.95	33.28	36.44	77.6	69.56
Accounts Payable	1.66	1.66	2.3	1.71	1.73	1.82
Accrued Expenses	0.08	0.08	0.42	0.44	0.29	0.22
Short-Term Debt	6.47	6.47	7.04	7.64	10.56	7.93
Current Portion of Leases	-	-	4.8	4.06	4.62	1.61
Current Income Taxes Payable	-	-	0.98	1.13	0.98	0.95
Current Unearned Revenue	-	-	4.45	2.57	-	0.4
Other Current Liabilities	8.51	8.51	9.57	7.6	12.63	0.68
Total Current Liabilities	16.72	16.72	29.56	25.15	30.81	13.62
Long-Term Debt	-	-	-	-	-	9.8
Long-Term Leases	-	-	-	0.03	0.14	0.07
Other Long-Term Liabilities	-	-	-	-	-	8.42
Total Liabilities	16.72	16.72	29.56	25.18	30.95	31.91
Common Stock	8.68	8.68	0	0	0.01	0.01
Additional Paid-In Capital	15.27	15.27	40.71	40.51	19.01	19.01
Retained Earnings	18.28	18.28	-35.49	-28.06	25.13	16.45
Comprensive Income & Other	-	-	-1.51	-1.19	2.5	2.17
Shareholders' Equity	42.23	42.23	3.72	11.26	46.65	37.65
Total Liabilities & Equity	58.95	58.95	33.28	36.44	77.6	69.56
Total Debt	6.47	6.47	11.85	11.73	15.31	19.41
Net Cash (Debt)	5.94	5.94	-10.03	-9	1.16	0.32
Net Cash Growth	-	-	-	-	262.99%	-
Net Cash Per Share	2.46	2.46	-4.16	-3.77	0.72	0.20
Filing Date Shares Outstanding	27.41	27.41	2.41	2.4	1.6	1.6
Total Common Shares Outstanding	2.41	2.41	2.41	2.4	1.6	1.6
Working Capital	35.33	35.33	-20.65	-14.49	-3.97	13.14
Book Value Per Share	17.52	17.52	1.54	4.69	29.16	23.53
Tangible Book Value	40.49	40.49	1.65	9.1	41.74	34.82
Tangible Book Value Per Share	16.79	16.79	0.69	3.79	26.09	21.76
Buildings	-	-	24.24	24.74	17.96	8.24
Machinery	-	-	8.14	8.3	8.91	5.23
Construction In Progress	-	-	0.02	0.01	16.89	23.96

Source: S&P Capital IQ. Standard template. Financial Sources.